Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Cogn Neurodyn ; 18(2): 581-595, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38699617

ABSTRACT

Parkinson's disease (PD) is a severe, progressive, neurological disorder. PD is not a single disease, but rather resembles a syndrome. PD includes two types of pathogenesis (i.e., classical PD and new PD). Clinically, PD patients present with a range of motor symptoms including decreased spontaneous movement, bradykinesia, muscle rigidity, changes in speech, and resting tremors. PD patients also often exhibit non-motor symptoms such as fatigue, sleep disorders, and emotional and mental health disturbances. Deep brain stimulation (DBS) performed in clinical neurosurgery has demonstrated considerable efficacy in the treatment of dyskinesia that occurs in PD patients. However, the specific neural mechanism of DBS remains unknown and is limited by several shortcomings that have hampered the popularization and development of the procedure. To address this issue, this study established a theoretical model of DBS for PD to investigate and understand the mechanism of DBS using several artificial intelligence (AI) algorithms. This model was used to investigate both classical PD and unheard-of new PD. The research described in this paper was as follows: a single neuron was used to establish a theoretical model of the basal ganglia circuit and to simulate the characteristic indicators of the potential release of the basal ganglia circuit in both normal and PD states. The state of the deep brain electrical stimulation in PD was then analyzed to identify the critical electrical stimulation index and the optimal target. We showed that the use of AI algorithms such as particle swarm optimization and other AI algorithms was beneficial for more detailed exploration and understanding of the mechanisms of DBS compared to those used in previous studies. This discovery may lead to advances in DBS technology and provide better treatment options for neurological diseases such as PD.

2.
Chem Senses ; 482023 01 01.
Article in English | MEDLINE | ID: mdl-37590987

ABSTRACT

While accumulating evidence implied the involvement of retro-nasal sensation in the consumption of nonvolatile taste compounds, it is still unclear whether it was caused by the taste compounds themselves, and if so, how can they migrate from the oral to nasal cavity. At first, we proposed aerosol particles as an alternative oral-nasal mass transfer mechanism. The high-speed camera approved that aerosol particles could be generated by the typical oral and pharynx actions during food oral processing; while the narrow-band imaging of nasal cleft and mass spectrometry of nostril-exhaled air approved the migration of aerosol within the oral-nasal route. Then, the "smelling" of taste compounds within the aerosol particles was testified. The four-alternative forced choices (4AFC) approved that the potential volatile residues or contaminants within the headspace air of pure taste solution cannot arouse significant smell, while the taste compounds embedded in the in vitro prepared aerosol particles can be "smelled" via the ortho route. The "smell" of sucrose is very different from its taste and the "smell" of quinine, implying its actual olfaction. The sweetness intensity of sucrose solution was also reduced when the volunteers' noses were clipped, indicating the involvement of retro-nasal sensation during its drinking. At last, the efficiency of aerosol as a mechanism of oral-nasal mass transfer was demonstrated to be comparable with the volatile molecules under the experimental condition, giving it the potential to be a substantial and unique source of retro-nasal sensation during food oral processing.


Subject(s)
Odorants , Smell , Humans , Odorants/analysis , Taste , Sucrose/pharmacology , Aerosols
SELECTION OF CITATIONS
SEARCH DETAIL
...